ANTIBIOTIC-RESISTANCE

ANTIBIOTIC-RESISTANCE

InnovationRx: Tarsus Pharmaceuticals Takes Aim At Disease-Causing Bugs

InnovationRx: Tarsus Pharmaceuticals Takes Aim At DiseaseCausing Bugs Tarsus Pharmaceuticals has made significant strides in the field of infectious disease treatment with the recent FDA approval of Xdemvy. This groundbreaking medication marks a major breakthrough in the fight against diseases caused by bacterial and fungal pathogens..

ANTIBIOTIC-RESISTANCE

China’s TenNor raises $41 million in series E financing

In a significant development in the biotech industry, TenNor Therapeutics has announced the successful completion of a $41 million series E funding round..